Although empirical, early treatment of acute inflammatory lesions and prevention of relapses can help improve outcomes in Behçet's disease

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.8, 2008-08, pp. : 13-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment strategies for Behçet's disease

By Fresko Izzet   Yazici Hasan  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3211-3219

Informa Healthcare

Access to resources Recommend Favorite

Treatment with once-daily transdermal rotigotine can improve Parkinsonian symptoms in patients with early Parkinson's Disease

By  

Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Thrombolytic Therapy for Acute Ischaemic Stroke: What Can We Do to Improve Outcomes?

By Demchuk Andrew M.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1833-1845

Adis International

Access to resources Recommend Favorite

Treatment-free remission with alemtuzumab in Behçet's disease

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Pancreatic Cancer and Personalized Medicine: Can Genomics Facilitate Early Diagnosis or Improve Therapeutic Outcomes?

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 1, 2010-03 ,pp. : 73-88

Bentham Science Publishers

Access to resources Recommend Favorite